Literature DB >> 11407682

Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study.

M Bukhari1, B Harrison, M Lunt, D G Scott, D P Symmons, A J Silman.   

Abstract

OBJECTIVE: To examine the time of occurrence of first radiographic erosions in a cohort of patients with inflammatory polyarthritis.
METHODS: Patients were recruited through the Norfolk Arthritis Register, which follows up patients annually. Patients with features of rheumatoid arthritis (other than erosions) sufficient, together with erosions, to meet the American College of Rheumatology (formerly, the American Rheumatism Association) 1987 revised criteria were requested to undergo radiographic examinations of the hands and feet at the first and/or second annual followup visits. All patients were requested to undergo radiographic examinations at the fifth annual followup visit. The most recent erosion-free radiograph was identified for 416 eligible patients, and these data were used to derive the duration of disease since the recalled date of onset of first symptoms. The rate of occurrence of first erosions was then determined (as a cumulative prevalence and as an incidence rate using Poisson regression) from analysis of followup films. Patients were assumed to be free of erosions at symptom onset.
RESULTS: The cumulative prevalence of erosions in patients whose first film was obtained 12-24 months after disease onset was 36%, equivalent to an incidence rate of 24.5/1,000 patient-months. We identified 3 analysis groups of patients who were free of erosions based on films obtained 12-24 months, 24-36 months, and 36-60 months since the recalled date of onset of first symptoms. New erosions were observed in all 3 groups, with cumulative prevalences of 23%, 28%, and 47%, respectively. These were equivalent to first-erosion incidence rates/1,000 patient-months of 5.4 (95% confidence interval [95% CI] 3.8-83), 6.8 (95% CI 4.7-10.0), and 13.0 (95% CI 8.9-19.2), respectively.
CONCLUSION: Many patients with erosive disease first develop their erosions >2 years from disease onset.

Entities:  

Mesh:

Year:  2001        PMID: 11407682     DOI: 10.1002/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

3.  Effect of Wenhua Juanbi recipe on proliferation and apoptosis of synoviocytes in rats with collagen-inducing arthritis.

Authors:  Xi-de Liu; Ying Chen; Feng-yun Liu; Li-hong Ye; Long Cai
Journal:  Chin J Integr Med       Date:  2011-06-29       Impact factor: 1.978

4.  A comparative study on the diversity of clinical features between the sero-negative and sero-positive rheumatoid arthritis patients.

Authors:  Yan Geng; Wei Zhou; Zhuo-Li Zhang
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

5.  Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Authors:  Eriko Kudo-Tanaka; Shiro Ohshima; Masaru Ishii; Toru Mima; Masato Matsushita; Naoto Azuma; Yoshinori Harada; Yoshinori Katada; Hitomi Ikeue; Mitsuko Umeshita-Sasai; Kunio Miyatake; Yukihiko Saeki
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

Review 6.  Early rheumatoid arthritis: toward tailor-made therapy.

Authors:  Robert B M Landewé; Désirée M F M van der Heijde
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

7.  Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.

Authors:  Mariem Ben Hamad; Sameh Marzouk; Neila Kaddour; Hatem Masmoudi; Faiza Fakhfakh; Ahmed Rebai; Zouhir Bahloul; Abdellatif Maalej
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

8.  Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis.

Authors:  Marwan Bukhari; Mark Lunt; Anne Barton; Dianne Bunn; Alan Silman; Deborah Symmons
Journal:  Ann Rheum Dis       Date:  2006-09-01       Impact factor: 19.103

9.  Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

Authors:  Tracey M Farragher; Mark Lunt; Bo Fu; Diane Bunn; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-26       Impact factor: 19.103

10.  Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis.

Authors:  A Barton; H Platt; F Salway; D Symmons; E Barrett; M Bukhari; M Lunt; E Zeggini; S Eyre; A Hinks; D Tellam; B Brintnell; W Ollier; J Worthington; A Silman
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.